TCL Archive Senate Subcommittee Agrees On $1.188 Billion NCI Budgt for FY 1985, $110 Million Increase Over ‘84 June 29, 1984
TCL Archive FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity? August 15, 1997
TCL Archive Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence December 26, 2008
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
